Iradimed (IRMD) Cash from Investing Activities (2013 - 2026)
Iradimed (IRMD) posted quarterly Cash from Investing Activities of -$443000.0 for Q2 2026, up 84.31% year-over-year from -$240352.0 in Q2 2025, and up 5.54% on a QoQ basis from -$469000.0 in Q1 2026.
Iradimed (IRMD) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Iradimed has reported Cash from Investing Activities for 14 years, with the latest figure at -$443000.0 in Q2 2026.
- Cash from Investing Activities for Q2 2026 came in at -$443000.0, up 84.31% year-over-year; the trailing twelve-month figure through Jun 2026 was -$2.6 million (up 81.23% YoY), and the FY2025 annual result was -$8.4 million, up 4.49% from the prior year.
- Cash from Investing Activities advanced to -$443000.0 in Q2 2026, from -$469000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $77561.0 in Q2 2022 and troughed at -$6.6 million in Q1 2023.
- A 5-year average of -$1.5 million and a median of -$517495.5 in 2022 frame the typical range for Cash from Investing Activities.
- The widest annual swing landed in 2023, when Cash from Investing Activities plunged 1443.94%; it then jumped 92.7% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$471676.0 in 2022, then tumbled by 34.16% to -$632816.0 in 2023, then plunged by 383.07% to -$3.1 million in 2024, then soared by 86.38% to -$416407.0 in 2025, then fell by 6.39% to -$443000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$443000.0 in Q2 2026, -$469000.0 in Q1 2026, and -$416407.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Iradimed | 1.11 Bn | 1.05 Bn | 15.16 Mn | -443,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -443,000.00 |
| Jun 30, 2026 | -443,000.00 |
| Mar 31, 2026 | -469,000.00 |
| Mar 31, 2026 | -469,000.00 |
| Dec 31, 2025 | -416,407.00 |
| Dec 31, 2025 | -416,407.00 |
| Sep 30, 2025 | -1.26 Mn |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -3.06 Mn |
| Dec 31, 2024 | -3.06 Mn |
| Sep 30, 2024 | -4.01 Mn |
| Sep 30, 2024 | -4.01 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | -478,803.00 |
| Mar 31, 2024 | -478,803.00 |